Picture of Feedback logo

FDBK Feedback News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

REG - Feedback PLC - Bleepa-CareLocker contract extension with QVH

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230404:nRSD2338Va&default-theme=true

RNS Number : 2338V  Feedback PLC  04 April 2023

Feedback plc

 

Bleepa-CareLocker contract extension with Queen Victoria Hospital

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist clinical
communication company, announces that it has been awarded a nine-month,
fixed-term contract extension of its contract for the Sussex Health and Care
Partnership Integrated Care System ("Sussex ICS") development programme with
Queen Victoria Hospital ("QVH") for Feedback's Bleepa-CareLocker Community
Diagnostics Centre ("CDC") solution.

 

This paid extension, which follows the success of the Company's existing
contract (details of which were announced by Feedback on 6 September 2022),
follows the abandonment of the Trust's previous procurement process in March
2023 and will cover the period from 1 April 2023 until 31 December 2023 whilst
QVH undertakes a new tender exercise under the Public Contracts Regulations
2015. A new tender process for the next phase of the CDC programme rollout is
due to commence imminently.

 

QVH is expected to procure the relevant components of the CDC programme,
including the digital pathway element, currently under contract with Feedback.

 

Dr Tom Oakley, CEO Feedback plc said: "Although QVH had expected to conclude
its tender process by 31(st) March 2023, we have been informed by the Trust
that the existing tender process is no longer progressing. We are pleased to
be supporting QVH on an interim basis to ensure the continuity of ongoing
patient care whist they undertake a further procurement exercise.

 

"The digital component of CDC delivery that Feedback provides is critical, and
we continue to champion the QVH CDC programme to other NHS organisations
through the continuation of this contract, and remain confident in the
emerging opportunity that CDCs represent both for the Company and the wider
NHS. While we continue to support QVH, the Company will actively explore
opportunities to support the wider CDC capability throughout the NHS."

 

This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014 as it forms part of UK law by virtue of the
European Union (Withdrawal) Act 2018.

 

 

-Ends-

 

Enquiries:

 

 Feedback plc                                    +44 (0) 20 3997 7634

 Tom Oakley, CEO                                 IR@fbk.com (mailto:IR@fbk.com)

 Anesh Patel, CFO

 Panmure Gordon (UK) Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Freddy Crossley (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd;                                Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                                 (mailto:feedbackplc@walbrookpr.com)
 Nick Rome/Joe Walker                            07748 325 236 or 07407 020  470

 

 

About Feedback

 

Feedback plc helps clinical teams to make better decisions faster for
patients. We design products that enhance clinician access to patient data and
to their colleagues. Our unique approach centres around individual patient
episodes, into which we pull relevant clinical data from hospital systems and
around which we build remote clinical teams for collaboration. As a result, we
produce a digital infrastructure that makes patient data available to
clinicians in multiple settings, in a format that enables them to meaningfully
interact with it, providing flexibility to clinicians and free movement of
patients between provider settings - clinicians can practice from anywhere and
patients can attend any care provider for treatment.

 

Our products Bleepa and CareLocker work together to deliver unparalleled value
to our customers. Bleepa is our application layer and sits on top of
CareLocker as our data layer. Bleepa is a clinician facing platform that
displays clinical results from a patient's CareLocker at a certified and
regulated quality, that is suitable for clinical use and enables dialogue on a
patient-by-patient basis with colleagues through a secure, auditable chat
interface that links back to the patient medical record. The CareLocker data
storage model is built around the patient. Our vision is one where relevant
clinical data is always available to the patient as well as to any care
setting that they may attend - a federated data architecture with the patient
as the tenant.

 

The Company has a number of growth opportunities domestically and
internationally across a range of markets including the NHS, the veterinary
market and private healthcare providers and its highly scalable Software as a
Service ("SaaS")-based revenue model is expected to provide increasing levels
of visibility as the Company grows its customer base.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCZZGGDGFZGFZZ

Recent news on Feedback

See all news